Ghazavi M - Search Results

1

The Hidradenitis Suppurativa Priority Setting Partnership.

Ingram JR, Abbott R, Ghazavi M, Alexandroff AB, McPhee M, Burton T, Clarke T. Ingram JR, et al. Among authors: ghazavi m. Br J Dermatol. 2014 Dec;171(6):1422-7. doi: 10.1111/bjd.13163. Epub 2014 Oct 30. Br J Dermatol. 2014. PMID: 24903313

2

Management of morphoea: results of a national survey of U.K. clinicians.

Warburton KL, McPhee MJ, Savage LJ, Honan AE, Montgomery R, Ghazavi M, Torley D, Shams K, Ingram JR. Warburton KL, et al. Among authors: ghazavi m. Br J Dermatol. 2014 Nov;171(5):1243-5. doi: 10.1111/bjd.13062. Epub 2014 Sep 26. Br J Dermatol. 2014. PMID: 24749777 Review. No abstract available.

3

Adalimumab for Treating Moderate-to-Severe Hidradenitis Suppurativa: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Tappenden P, Carroll C, Stevens JW, Rawdin A, Grimm S, Clowes M, Kaltenthaler E, Ingram JR, Collier F, Ghazavi M. Tappenden P, et al. Among authors: ghazavi m. Pharmacoeconomics. 2017 Aug;35(8):805-815. doi: 10.1007/s40273-017-0488-2. Pharmacoeconomics. 2017. PMID: 28176188 Free article. Review.

4

International, prospective cohort study comparing non-absorbable versus absorbable sutures for skin surgery: CANVAS service evaluation.

Lee A, Stanley GHM, Wade RG, Berwick D, Vinicombe V, Salence BK, Musbahi E, De Poli ARCS, Savu M, Batchelor JM, Abbott RA, Gardiner MD, Wernham A, Veitch D; CANVAS collaborative. Lee A, et al. Br J Surg. 2023 Mar 30;110(4):462-470. doi: 10.1093/bjs/znad008. Br J Surg. 2023. PMID: 36753053 Free article.

5

UK Dermatology Clinical Trials Network's STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial.

Craig FF, Thomas KS, Mitchell EJ, Williams HC, Norrie J, Mason JM, Ormerod AD; UK Dermatology Clinical Trials Network’s STOP GAP Trial Team. Craig FF, et al. Trials. 2012 Apr 28;13:51. doi: 10.1186/1745-6215-13-51. Trials. 2012. PMID: 22540770 Free PMC article. Clinical Trial.

6

Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial.

Ormerod AD, Thomas KS, Craig FE, Mitchell E, Greenlaw N, Norrie J, Mason JM, Walton S, Johnston GA, Williams HC; UK Dermatology Clinical Trials Network’s STOP GAP Team. Ormerod AD, et al. BMJ. 2015 Jun 12;350:h2958. doi: 10.1136/bmj.h2958. BMJ. 2015. PMID: 26071094 Free PMC article. Clinical Trial.

7

Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: A prospective cohort study.

Thomas KS, Ormerod AD, Craig FE, Greenlaw N, Norrie J, Mitchell E, Mason JM, Johnston GA, Wahie S, Williams HC; UK Dermatology Clinical Trials Network's STOP GAP Team. Thomas KS, et al. J Am Acad Dermatol. 2016 Nov;75(5):940-949. doi: 10.1016/j.jaad.2016.06.016. Epub 2016 Aug 5. J Am Acad Dermatol. 2016. PMID: 27502313

8

An outbreak of occupational allergic contact dermatitis caused by 2-N-octyl-4-isothiazolin-3-one among workers in an adhesive factory.

Ghazavi MK, Johnston GA. Ghazavi MK, et al. Contact Dermatitis. 2011 Feb;64(2):114-5. doi: 10.1111/j.1600-0536.2010.01838.x. Contact Dermatitis. 2011. PMID: 21210827 No abstract available.

9

Photo-allergic contact dermatitis caused by isoamyl p-methoxycinnamate in an 'organic' sunscreen.

Ghazavi MK, Johnston GA. Ghazavi MK, et al. Contact Dermatitis. 2011 Feb;64(2):115-6. doi: 10.1111/j.1600-0536.2010.01839.x. Contact Dermatitis. 2011. PMID: 21210828 No abstract available.

10

Insulin allergy.

Ghazavi MK, Johnston GA. Ghazavi MK, et al. Clin Dermatol. 2011 May-Jun;29(3):300-5. doi: 10.1016/j.clindermatol.2010.11.009. Clin Dermatol. 2011. PMID: 21496738 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page